The University of Chicago Header Logo

Connection

Jonathan Chung to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Jonathan Chung has written about Xenograft Model Antitumor Assays.
Jonathan Chung
Connection Strength
0.076
Xenograft Model Antitumor Assays
  1. Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. Clin Cancer Res. 2020 11 15; 26(22):5974-5989.
    View in: PubMed
    Score: 0.040
  2. RET rearrangements are actionable alterations in breast cancer. Nat Commun. 2018 11 16; 9(1):4821.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.